Loading…
Based on limited metadata with no full letter text available, this warning letter was issued to Nexus Vapour on July 26, 2018, regarding products classified as drugs. Without access to the detailed subject line and letter contents, the specific nature of the violations cannot be determined from the metadata alone. The letter falls under FDA's drug regulatory authority, though the specific issuing office is not identified in the available information. To understand the particular compliance issues cited, the complete warning letter text would be required.